GROUP
February 27, 2023
We are so excited to congratulate our PI Melody Swartz on her election to the National Academy of Engineering! Melody was also elected into the Royal Academy of Medicine of Belgium in 2023.
Read more in the UChicago News article here.
October 7th, 2022
Read Andrew Nellis' take on a story by our alumn Dr. Priscilla Briquez and Dr. Melody Swartz, shedding new light on the causes of severe Covid.
Priscilla Briquez
Assitant Professor
University of Freiburg, Germany
Melody Swartz
William B. Ogden Professor of Molecular Engineering
University of Chicago, USA
“We’ve known that COVID-19 enters cells via the ACE2 receptor,” said Priscilla Briquez, first author of the paper and PME postdoctoral researcher during the study, now an assistant professor at the University of Freiburg. “But the question became how the entry of the virus would impair blood pressure regulation. Most people focused on the receptor alone, but we suspected an autoimmune response would be equally likely.”
September 7th, 2022
Traditional apple picking trip with our lovely sister lab - fall in the MidWest is magical... and tasty.
August 18, 2022
Congratulations to
Danielle Brennan and Katie Shelmidine
of this summers
Research Experience for Undergraduates.
It was a joy having you in the lab, you presented great results during the REU poster session and we cannot wait to see what endeavors you chose to embark upon next.
Thank you also to this years supervisors from the Swartz lab Calixto Mateo Salles and Alexandra Isabelle Magold.
Read more about the PME REU program here.
August 12, 2022
Congratulations to another PhD coming out of the Swartz lab.
Rachel has chosen a fascinating new carreer path if you want to learn more, read her interview for PME NEWS below.
Rachel gives a fascinating look into her work and her mission deciphering the secrets of cancer immunology and developing new tools, to help stem the tide against one of the worst and most wide spread diseases of our times.
"Rachel Weathered, PhD’22, applies her scientific expertise to investment strategy, guiding financial firms through one of medicine’s most promising new fields."
Read more about Rachels story at PME NEWS.
July, 2022
Thanks to our PostDoc Anish Mukerjee, our special journal club for undergatuate and summer students
is up and running.
Here you will learn how to read a paper and understand what it means in a greater scientific context.
Also it's a ton of fun, contact Anish for more information.
December 23rd, 2021
The famous Big Brains podcast talked to our own Profs. Swartz and Hubbell.
A wonderfully easy way to learn, who we are,
what we do and why we do it in our PIs words.
Have fun and a happy New Year from all of us!
March 24th, 2021
PME featuring our latest Science Advances paper.
A collaborative effort together with the Hubbell group, our study introduces the potential of lymphangiogenesis induction as a novel immunotherapeutic strategy to consider in cancer vaccine design.
For the whole story please go to
https://advances.sciencemag.org/content/7/13/eabe4362
For the feature please go to
https://pme.uchicago.edu/news/exploiting-cancer-cells-aid-their-own-destruction
October 19th, 2020
Melody Swartz elected to
the National Academy of Medicine
Our very own Melody Swartz has been elected to the National Academy of Medicine.
The good news is featured by the Pritzker School of Molecular Engineering and online:
-
Facebook: https://www.facebook.com/UChicagoPME/posts/3340473442714457
-
LinkedIn: https://www.linkedin.com/feed/update/urn:li:activity:6723980456770990080
-
Twitter: https://twitter.com/UChicagoPME/status/1318215241336016896
-
Instagram: https://www.instagram.com/p/CGh83YZFwnW/
-
Faculty accolades page: https://pme.uchicago.edu/about/faculty-accolades
June 22nd-24th 2020
AACR 2020
It is good to check in with our collaborators around the globe at the annual meeting of the American Association for Cancer Research.
Due to Covid19 this years meeting is virtual and registration is free.
Getting a closer look at our latest work has never been easier.
Watch a presentation by Melody Swartz
on June 24, 2020 at 2:15 PM U.S. EDT,
Session MW12 - Emerging Models: Bring in the Engineers
"In vitro models of the tumor-immune interface".
AACR 2020
Our very own Nick, Maria Stella and Peyman have presented their latest findings at AACR online.
For more information click on their abstracts.
Immune Mechanisms Invoked by Therapies 2
June 22, 2020, 9:00 AM - 6:00 PM
2253 / 6 - Lymphangiogenesis augments the anti-tumor efficacy of radiotherapy in mouse melanoma
By Nick Mitrousis
Immunomodulatory Agents and Interventions
June 23, 2020, 9:20 AM - 9:30 AM
1072 - Lymphangiogenesis-inducing vaccines for melanoma treatment elicit potent tumor-specific T cell immunity and long-term tumor control
By Maria Stella Sasso
Novel Immunotherapies and Mechanisms
June 23, 2020, 9:20 AM - 9:30
5695 Induction of lymphangiogenesis in breast cancer enhances responsiveness to immunotherapies
By Peyman Hosseinchi
June 12th, 2020
CIIC featuring our latest nature paper.
A collaborative effort together with the Sperling group, our study investigates the role of pro-lymphangiogenic VEGFR-3 signaling in allergic airway inflammation.
For the whole story please go to
https://www.nature.com/articles/s41385-020-0308-4
May 26th, 2020
Chicago Maroon discusses PME Covid Resesearch
Research at the CIIC includes cancer immunotherapy and therapies for fruit allergies. But recently, the CIIC has focused a large effort toward COVID-19 research. Currently, there are projects for creating a vaccine for the disease led by Jeffrey Hubbell and Melody Swartz, co-directors of the center.
“The vaccine projects harmoniously bring together the resources of Pritzker School of Molecular Engineering and medical centers across the country,” Hubbell said.
To read the article please follow the link below.
https://www.chicagomaroon.com/article/2020/5/27/immunoengineering-center-investigates-covid-19-vac/
April 24th, 2020
Congratulations to our Nick Mitrousis, PhD.
Nick's innovative work on exploring the role of lymphangiogenesis
in the anti-tumor immune response to radiotherapy
is being supported by the CIHR's postdoctoral fellowship.
